Actively Recruiting

Age: 18Years +
All Genders
NCT06673043

Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus

Led by AstraZeneca · Updated on 2026-05-13

100

Participants Needed

11

Research Sites

174 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The Polish multicentre observational (non-interventional) study aiming to collect data on the characteristic of patients with systemic lupus erythematosus and clinical outcomes of anifrolumab administered in the scope of routine clinical practice.

CONDITIONS

Official Title

Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients aged 18 years or older with systemic lupus erythematosus (SLE) receiving anifrolumab treatment under the National Drug Program in Poland
  • Patients willing to participate and able to provide signed informed consent
Not Eligible

You will not qualify if you...

  • Participation in any previous anifrolumab clinical trial or planned participation in any clinical trial on or after the first anifrolumab infusion through the National Drug Program
  • Cognitive incapacity, unwillingness, or language barriers that prevent proper understanding or cooperation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 11 locations

1

Research Site

Bydgoszcz, Poland

Actively Recruiting

2

Research Site

Bytom, Poland

Actively Recruiting

3

Research Site

Gdansk, Poland

Actively Recruiting

4

Research Site

Katowice, Poland

Actively Recruiting

5

Research Site

Krakow, Poland

Actively Recruiting

6

Research Site

Lodz, Poland

Actively Recruiting

7

Research Site

Lublin, Poland

Actively Recruiting

8

Research Site

Poznan, Poland

Actively Recruiting

9

Research Site

Rzeszów, Poland

Actively Recruiting

10

Research Site

Warsaw, Poland

Actively Recruiting

11

Research Site

Wroclaw, Poland

Actively Recruiting

Loading map...

Research Team

A

AstraZeneca Clinical Study Information Center

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus | DecenTrialz